Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$29.97 - $47.42 $455,544 - $720,784
-15,200 Reduced 73.79%
5,400 $200,000
Q2 2024

Aug 14, 2024

BUY
$38.07 - $52.25 $114,210 - $156,750
3,000 Added 17.05%
20,600 $980,000
Q1 2024

May 15, 2024

BUY
$27.67 - $39.61 $63,641 - $91,103
2,300 Added 15.03%
17,600 $673,000
Q4 2023

Feb 14, 2024

BUY
$30.6 - $43.78 $345,780 - $494,714
11,300 Added 282.5%
15,300 $477,000
Q3 2023

Nov 14, 2023

SELL
$39.39 - $58.12 $70,902 - $104,616
-1,800 Reduced 31.03%
4,000 $160,000
Q2 2023

Aug 14, 2023

BUY
$50.45 - $72.82 $292,610 - $422,355
5,800 New
5,800 $304,000
Q4 2022

Feb 14, 2023

SELL
$46.82 - $76.2 $580,568 - $944,880
-12,400 Reduced 90.51%
1,300 $63,000
Q3 2022

Nov 14, 2022

BUY
$70.55 - $111.58 $966,535 - $1.53 Million
13,700 New
13,700 $967,000

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.35B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.